Internal melanoma is genuinely rare. Mucosal melanomas, which arise inside the body on surfaces like the nasal passages, mouth, gastrointestinal tract, and genital region, account for roughly 1 to 2 percent of all melanoma cases. Uveal melanoma, which forms inside the eye, is the most common eye cancer in adults but still makes up only about 5 percent of all melanomas. Because these tumors grow in places you cannot easily see or feel, they tend to be caught later and behave more aggressively than the skin melanomas most people think of. The signs vary dramatically depending on where the tumor sits, and many of them mimic far more common conditions.
Why Melanoma Can Start Inside the Body
Most people associate melanoma with sun-damaged skin, so the idea of melanoma developing deep inside the body can be confusing. The explanation goes back to where melanocytes, the pigment-producing cells that give rise to melanoma, actually live. Melanocytes develop from a group of embryonic cells called the neural crest, which migrate throughout the body during fetal development.1PubMed. Human melanocyte biology, toxicology, and pathology While most melanocytes settle in the skin, some end up in the mucous membranes lining the sinuses, mouth, esophagus, intestines, and genital tract. Others take up residence in the eye’s uveal layer. Any melanocyte, regardless of location, can undergo the DNA damage and mutations that lead to cancer.
Crucially, the mutations driving internal melanomas are not the same ones behind typical sun-related skin melanoma. Genome sequencing has shown that mucosal melanomas lack the UV-damage mutation signatures seen in cutaneous melanoma and instead carry substantially more structural rearrangements in their DNA.2PubMed. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma Uveal melanomas are driven by yet another set of mutations, most commonly in the GNAQ or GNA11 genes, which are altered in the vast majority of cases.3PubMed. Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data In practical terms, this means internal melanomas are biologically distinct diseases from the melanoma you get on sun-exposed skin. They arise by different pathways, they respond differently to treatment, and they require different surveillance strategies.
Where Internal Melanoma Develops
Internal melanomas cluster in a few general locations. The broadest categories are mucosal melanoma and uveal melanoma, and within those, several specific sites stand out.
Mucosal melanomas most commonly originate in three regions: the head and neck (especially the nasal cavity and sinuses, but also the mouth), the anorectal area, and the vulvovaginal region.4PubMed. Mucosal Melanoma: Epidemiology, Biology and Treatment Less frequently, primary melanomas arise in the esophagus, stomach, or small intestine, though gastrointestinal melanoma is exceptionally rare and sometimes controversial to distinguish from a metastasis that traveled from an undetected skin primary.
Uveal melanoma develops in the pigmented layer of the eye, most often in the choroid but sometimes in the iris or ciliary body. Separately, there are cases classified as melanoma of unknown primary, where melanoma appears in lymph nodes or internal organs without any identifiable skin lesion. These make up about 3 to 4 percent of all melanomas, and there is a trend toward more visceral cases being identified in recent years.5PubMed. Melanoma of unknown primary: New perspectives for an old story One leading explanation is that the original skin melanoma spontaneously regressed before it was ever noticed, leaving behind metastatic deposits inside the body.
Signs of Mucosal Melanoma by Location
The challenge with mucosal melanoma is that nearly every symptom it produces overlaps with something far more common and benign. This is one of the main reasons these cancers tend to be diagnosed at an advanced stage.
Head and Neck
Sinonasal melanoma, which grows in the nasal cavity or paranasal sinuses, is the most common form of head and neck mucosal melanoma. The most frequently reported symptoms are nasal obstruction and nosebleeds, but these develop late and are easily attributed to allergies, sinusitis, or nasal polyps.6PubMed Central. Sinonasal Melanoma: A Case Report and Literature Review In some cases, the tumor grows silently until it invades neighboring structures. There are documented instances of sinonasal melanoma extending into the eye socket, causing vision loss, bulging of the eye, restricted eye movement, and swelling of the tissue over the white of the eye.7PubMed. Sinonasal mucosal melanoma presenting with ocular symptoms: Two case reports and a literature review Oral mucosal melanoma, which can arise on the gums, palate, or inner cheeks, may show up as a dark patch or a non-healing sore in the mouth. Because these areas are not routinely inspected by most people, the tumor often grows unnoticed for months.
Gastrointestinal Tract
Primary melanoma of the gastrointestinal tract can develop anywhere from the esophagus to the rectum. Symptoms depend entirely on location and can include abdominal pain, bleeding (sometimes showing up as dark or tarry stool), weight loss, nausea, difficulty swallowing in esophageal cases, or bowel obstruction.8PubMed Central. Primary melanoma of the gastrointestinal tract These symptoms closely mimic those of other gastrointestinal tumors, as well as ulcers, inflammatory bowel disease, and other common conditions. Fatigue, anemia from chronic blood loss, and constipation can all be part of the picture.9Mayo Clinic Proceedings. Metastatic Malignant Melanoma of the Gastrointestinal Tract: Report of 2 Cases and Review of the Literature One wrinkle: the GI tract is actually a common site for melanoma metastases that spread from the skin, so when melanoma is found in the stomach or intestines, doctors often need to investigate whether it originated there or arrived from elsewhere.
Vulvovaginal and Anorectal
Vaginal melanoma is extremely rare, highly aggressive, and tends to present with abnormal vaginal bleeding, which in older women is frequently the first sign.10PubMed Central. A Case Report on Vaginal Melanoma, a Fast, Progressive Disease Vulvar melanoma may appear as a pigmented lesion on the external genitalia that changes in size or bleeds. Anorectal melanoma often causes rectal bleeding, a palpable mass, or changes in bowel habits. In all these locations, the tumor is frequently mistaken for a hemorrhoid, benign polyp, or other common condition. Because these areas are not regularly self-examined and carry social stigma that can delay medical visits, diagnosis often comes late.
Uveal Melanoma and Its Particular Behavior
Uveal melanoma deserves separate attention because it behaves quite differently from mucosal melanomas. It develops inside the eye, usually in the choroid, and patients may notice blurred vision, flashes of light, a growing dark spot on the iris, or a gradual loss of peripheral vision. Some cases are caught incidentally during routine eye exams. However, failures of detection and diagnosis still occur commonly, and the tumor threatens both vision and life from metastatic spread.11PubMed. Developments in the management of uveal melanoma
A study of over 2,300 patients in the United Kingdom found that 23 percent reported their tumor was initially missed by a healthcare provider, and those patients had more advanced tumors by the time they reached a specialist center. The median time from referral to treatment was 49 days, and in roughly one in five patients, that delay exceeded six months. Patients whose tumors had been missed initially experienced significantly longer delays, with a median of 92 days compared to 40 days for those diagnosed promptly.12PubMed. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients
What makes uveal melanoma particularly dangerous is how it spreads. Unlike skin and mucosal melanomas, which tend to travel first through the lymphatic system, uveal melanoma spreads almost exclusively through the bloodstream. The choroid is a highly vascular layer without the kind of structural barrier that tumor cells need to breach in most other melanoma types. The result is a high frequency of circulating tumor cells and a strong tendency for the cancer to metastasize to the liver.13PubMed Central. Management of liver metastases from uveal melanoma Roughly half of patients with uveal melanoma eventually develop liver metastases, sometimes years or even a decade after the eye tumor was treated. This long delay makes surveillance challenging and underscores why routine follow-up is critical.
Why These Cancers Are Caught Late
Several forces conspire to delay diagnosis of internal melanoma. The first is simple anatomy: you cannot see a melanoma growing inside your nasal cavity, rectum, or eye the way you can spot a suspicious mole on your arm. Mucosal melanomas present at a later stage on average and carry a worse prognosis regardless of the stage at diagnosis compared with skin melanomas.4PubMed. Mucosal Melanoma: Epidemiology, Biology and Treatment
The second factor is symptom overlap. A nosebleed, some rectal bleeding, or a bout of indigestion sends most people (and many doctors) toward the most common explanation first, which is almost never melanoma. The symptoms of internal melanoma are nonspecific by nature, and the rarity of the disease means it is low on the list of differential diagnoses.
A third, less discussed factor is access to care. Insurance status measurably affects the stage at which melanoma is diagnosed. Among nearly 180,000 melanoma cases in the United States, people with Medicaid had roughly three times the odds of being diagnosed at a late stage compared to those with private insurance, and uninsured individuals had about twice the odds.14PubMed. Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States While that study covered all melanoma types, the barriers are only magnified for internal forms that require specialist evaluation or imaging to detect. Regular dilated eye exams, for instance, are the main path to catching uveal melanoma early, and people without consistent healthcare access are less likely to receive them.
What Makes Diagnosis Complicated
Even when a suspicious internal mass is found, confirming that it is melanoma is not always straightforward. Some internal melanomas are amelanotic, meaning they produce little or no visible pigment. This strips away one of the classic visual clues that pathologists rely on. In those cases, specialized staining with markers like HMB-45, which reacts with melanoma cells even when they lack pigment, becomes essential for confirming the diagnosis.15PubMed Central. Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma Without it, an amelanotic internal melanoma can be misdiagnosed as a different type of cancer or even a benign growth.
The genetic profiling of the tumor also matters more for internal melanomas than for most skin melanomas. Different subtypes carry different driver mutations. In a large genomic analysis, mucosal melanomas showed frequent alterations in NRAS, KIT, and NF1, while uveal melanomas were overwhelmingly driven by GNAQ or GNA11 mutations, which were present in about 87 percent of cases.3PubMed. Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data Head and neck mucosal melanomas in particular showed low rates of BRAF mutations, the target of some of the most successful skin-melanoma drugs.16PubMed. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases Getting the mutation profile right helps oncologists decide which therapies are likely to work and which are not worth trying.
How Treatment Differs from Skin Melanoma
One of the more frustrating realities of internal melanoma is that the treatments that have transformed outcomes for skin melanoma do not work nearly as well here. Immune checkpoint inhibitors, the drugs that have dramatically improved survival in advanced cutaneous melanoma over the past decade, show only modest benefit in mucosal melanoma.17PubMed. Therapeutic Approaches to Mucosal Melanoma This is at least partly explained by the different genetic makeup of these tumors. Mucosal melanomas tend to have a lower burden of mutations overall, which may mean fewer signals for the immune system to recognize and attack.
Surgery remains the primary treatment when the tumor can be fully removed, and early detection provides the best chance at long-term survival. For mucosal melanomas in the head and neck, this often means complex procedures in tight spaces near the brain and eyes. Anorectal and vulvovaginal melanomas may require surgeries that significantly affect quality of life. Radiation is used in some cases as an adjunct, particularly for sinonasal melanoma where clear surgical margins are hard to achieve.
For uveal melanoma, treatment of the primary eye tumor has evolved considerably, with radiation plaque therapy and proton beam therapy often allowing preservation of the eye. But the real clinical challenge is the liver metastases that develop in roughly half of patients. Uveal melanoma’s tendency to spread through the bloodstream directly to the liver, bypassing lymph nodes, means that the approach required is fundamentally different from managing metastatic skin melanoma.
Combination therapies involving drugs that target blood vessel growth (antiangiogenic agents) are being explored for mucosal melanoma, with early signals that they may offer improvements over checkpoint inhibitors alone.17PubMed. Therapeutic Approaches to Mucosal Melanoma For uveal melanoma, tebentafusp, a bispecific T-cell engager, became the first drug to show a survival benefit in metastatic disease, marking a milestone for a subtype that had long resisted treatment advances.
When Melanoma Reaches the Brain Lining
One particularly feared complication of advanced melanoma, whether it started on the skin or internally, is leptomeningeal disease, in which cancer cells infiltrate the membranes surrounding the brain and spinal cord. The symptoms are varied and can include headache, nausea, vomiting, double vision, weakness, and neurological deficits that seem to come from multiple locations at once.18PubMed Central. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases Leptomeningeal disease is rare even among patients with advanced melanoma, but its prognosis is poor and it can be difficult to distinguish from other neurological conditions without specialized imaging and cerebrospinal fluid analysis. Awareness of this possibility matters because early recognition, while it does not change the overall prognosis dramatically, can help manage symptoms and guide treatment decisions.
Emerging Approaches to Earlier Detection
Because the main obstacle to better outcomes in internal melanoma is late diagnosis, there is growing interest in blood-based tests that could flag cancer earlier or monitor it after treatment. Liquid biopsy, which analyzes circulating tumor DNA and other tumor-derived material in a standard blood draw, has shown promise in melanoma. These techniques can detect tumor-specific genetic fragments in the bloodstream, offering a way to monitor treatment response, predict relapse in high-risk patients, and potentially catch recurrence before it becomes clinically apparent.19PubMed Central. Liquid biopsy for diagnostic and prognostic evaluation of melanoma
Circulating tumor DNA has been particularly studied in melanoma patients after surgery, where rising levels can signal that the cancer is returning before imaging picks it up.20PubMed Central. Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma For uveal melanoma, where the window between detectable circulating tumor cells and overt liver metastases can be years, this kind of monitoring could eventually change how aggressively patients are surveilled after their initial treatment. These tools are still largely in the research and clinical-trial phase rather than routine use, but they represent one of the more realistic paths toward catching internal melanoma recurrences earlier.
Who Should Pay Attention
There is no widely agreed-upon screening protocol for mucosal or uveal melanoma in the general population, and given their rarity, mass screening would not be cost-effective. But certain groups face higher risk and deserve closer attention. Uveal melanoma is more common in people with lighter skin, light-colored eyes, and certain inherited conditions like BAP1 tumor predisposition syndrome. Mucosal melanoma incidence increases with age, and head and neck forms may be somewhat more common in certain East Asian populations, where mucosal and acral melanomas make up a larger share of melanoma cases overall.
The practical takeaway for everyone is awareness of warning signs that are easy to dismiss. Persistent one-sided nasal obstruction or nosebleeds that do not resolve with usual treatment warrant investigation. Unexplained rectal bleeding, a vaginal mass, or postmenopausal bleeding should be evaluated rather than attributed to common conditions without examination. And a routine dilated eye exam remains the simplest way to catch uveal melanoma early, before symptoms develop. For anyone with a personal or family history of melanoma, these habits become especially important, since having had one melanoma increases the lifetime risk of developing another, including at an internal site.